Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,113 | 997 | 98.9% |
| Education | $151.69 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,258 | 256 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,288 | 86 | $0 (2024) |
| Amgen Inc. | $946.62 | 72 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $774.32 | 62 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $732.90 | 47 | $0 (2020) |
| Amarin Pharma Inc. | $627.34 | 45 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $557.24 | 41 | $0 (2023) |
| GlaxoSmithKline, LLC. | $511.44 | 39 | $0 (2023) |
| ABBVIE INC. | $477.28 | 41 | $0 (2024) |
| Lilly USA, LLC | $452.31 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $649.35 | 38 | Novo Nordisk Inc ($206.84) |
| 2023 | $953.07 | 65 | Novo Nordisk Inc ($424.62) |
| 2022 | $534.09 | 38 | Novo Nordisk Inc ($492.07) |
| 2021 | $694.17 | 59 | Novo Nordisk Inc ($256.70) |
| 2020 | $1,119 | 83 | Novo Nordisk Inc ($189.88) |
| 2019 | $2,891 | 212 | Novo Nordisk Inc ($462.32) |
| 2018 | $2,887 | 249 | Novo Nordisk Inc ($599.82) |
| 2017 | $3,536 | 260 | Novo Nordisk Inc ($625.47) |
All Payment Transactions
1,004 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Obesity | ||||||
| 12/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PAIN | ||||||
| 11/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neurology | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Obesity | ||||||
| 08/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PAIN | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Inflammation | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Respiratory | ||||||
| 06/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 317 | 318 | $100,930 | $16,167 |
| 2022 | 10 | 691 | 739 | $284,388 | $36,468 |
| 2021 | 14 | 1,990 | 2,239 | $731,475 | $183,290 |
| 2020 | 19 | 2,489 | 2,878 | $563,081 | $183,382 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $52,753 | $7,459 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 51 | $29,073 | $4,077 | 14.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $6,543 | $1,611 | 24.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $6,158 | $1,582 | 25.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 25 | $2,659 | $849.25 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 52 | 52 | $3,744 | $588.60 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 249 | $122,010 | $13,304 | 10.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 188 | 188 | $98,512 | $11,312 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 63 | $21,357 | $3,202 | 15.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 17 | 17 | $12,699 | $2,946 | 23.2% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $11,052 | $2,911 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 159 | 161 | $12,558 | $1,218 | 9.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $2,684 | $717.86 | 26.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $1,224 | $412.22 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $1,122 | $378.18 | 33.7% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2022 | 15 | 15 | $1,170 | $66.27 | 5.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 517 | 517 | $263,597 | $77,782 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 353 | 537 | $253,458 | $57,832 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 161 | $52,369 | $11,688 | 22.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 44 | 44 | $32,022 | $8,349 | 26.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 94 | 94 | $22,936 | $6,134 | 26.7% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 23 | 23 | $20,367 | $5,518 | 27.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 19 | 22 | $23,482 | $5,456 | 23.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 369 | 384 | $29,082 | $3,845 | 13.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $8,290 | $2,137 | 25.8% |
About Dr. Alvin Schmidt, MD
Dr. Alvin Schmidt, MD is a Internal Medicine healthcare provider based in West Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275640187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alvin Schmidt, MD has received a total of $13,264 in payments from pharmaceutical and medical device companies, with $649.35 received in 2024. These payments were reported across 1,004 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,113).
As a Medicare-enrolled provider, Schmidt has provided services to 5,487 Medicare beneficiaries, totaling 6,174 services with total Medicare billing of $419,307. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location West Orange, NJ
- Active Since 08/24/2006
- Last Updated 11/27/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275640187
Products in Payments
- FARXIGA (Drug) $1,059
- Ozempic (Drug) $982.82
- Victoza (Drug) $843.85
- Vascepa (Drug) $627.34
- XARELTO (Drug) $612.89
- JANUVIA (Drug) $543.49
- JARDIANCE (Drug) $524.68
- Rybelsus (Drug) $414.23
- Aimovig (Biological) $325.47
- Prolia (Biological) $323.64
- BREO (Drug) $304.88
- Tresiba (Drug) $268.80
- Trintellix (Drug) $246.29
- TRULICITY (Drug) $215.66
- Mitigare (Drug) $208.95
- VRAYLAR (Drug) $205.12
- Repatha (Biological) $177.97
- ENTRESTO (Drug) $169.65
- UBRELVY (Drug) $158.95
- Saxenda (Drug) $158.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Orange
Dr. David Dobesh, Md, MD
Internal Medicine — Payments: $83,628
Dr. Abel Gonzalez, M.d, M.D
Internal Medicine — Payments: $21,675
Dr. David Rahni, M.d, M.D
Internal Medicine — Payments: $14,217
Andrew Baddoo, M.d, M.D
Internal Medicine — Payments: $12,461
Larry Siu, Md, MD
Internal Medicine — Payments: $10,598
David Pineles, M.d, M.D
Internal Medicine — Payments: $9,136